Lactoferrin & Next-Generation Recombinant Proteins Shaping the Future of Infant Formula

• Exploring strategic pathways for recombinant LF that balance commercial opportunities in adult nutrition with extended regulatory timelines in infant nutrition
• Examining how LF bridges functional bioactive gaps between breast milk and formula to support improved infant health outcomes, including discussion of a preclinical infant mouse study evaluating the effects of oral LF on the gut microbiome and intestinal barrier
• Translating lessons from previous novel ingredient launches in infant formula into actionable approaches for regulatory approval and geographic expansion

Speakers:

Jules Lourie

Head of Scientific Affairs & Partnerships

TurtleTree